INTERNATIONAL DRUG REPURPOSING CONFERENCE
The iDR Conference Series is an annual global conference series where key opinion leaders from both the research and patient communities, funders, regulators and representatives from the private sector participate to collectively advance innovative drug repurposing in Europe and beyond.
Why join iDR?
Connect with global experts and key opinion leaders and learn first-hand why and how drug repurposing is fast evolving to revolutionise the medicine development landscape.
What to expect in iDR Conference Series?
Discover benefits
Discover how patient communities, researchers, industry and health authorities can benefit from cutting-edge drug repurposing.
Explore innovative ideas
In collaboration with key stakeholders and experts, explore innovative ideas to remove major roadblocks.
Open discussions
Discuss the current drug repurposing landscape and the challenges its faced with.
Share knowledge
Become part of a wider community that works together and shares knowledge, experiences and best practices.
Who is it for?
iDR24 Highlights
iDR24 Event Highlights
Why you shouldn’t miss the next iDR Conference
Insights from iDR24
Speakers
Listen to some of our key speakers of the 2024 event and their insights on the importance of the iDR Conference Series.
Interested in becoming a sponsor of this event?
Showcase your business to a diverse audience, including researchers, the patient community, funders, regulators, and representatives from the private sector. As a sponsor, you'll get unique visibility through strategic logo placements, exhibition space, social media exposure, networking opportunities, and more. Contact our sponsorship team at sponsorship@remedi4all.org to find out more about the various sponsorship packages available.
Contact sponsorship teamCo-organisers
REMEDi4ALL
REMEDi4ALL is an EU-funded research initiative that is driving forward the repurposing of medicines in Europe.
Beacon for rare diseases
Beacon is a UK-based charity that is building a united rare disease community with patient groups at its heart.